You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
RITAMIX(01936.HK)就製造及供應NMN膳食補充劑訂合作協議
阿思達克 12-09 09:26
RITAMIX(01936.HK)公布,公司與馬來西亞上市的科鼎控股之全資附屬,就科鼎向中國及東南亞(包括馬來西亞)市場製造及供應NMN膳食補充劑訂立合作協議。科鼎及集團亦將與馬來西亞理工大學合作,以進行基於NMN的保健品的研究。

集團指,NMN為一種前體,或者說為製造煙醯胺腺嘌呤二核(甘)酸(NAD+)的成分,而NAD+為一種於人類細胞內發現的重要輔(酉每),用於進行葡萄糖代謝等細胞過程。研究發現,NAD+的水平會隨著生物體老化而下降,從而令許多生物功能減慢。食用NMN膳食補充劑(主要以膠囊或粉末形式銷售)的主要原因為提高人體NAD+的水平。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account